Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction

• by Yanlong Zhao, Haodong Jiang, Yuanyuan Zhao, Shuai Wang, Qicheng Yu, Jing Zeng, Shan Xie, Jiatong Li, Zhi Liu

• July 2, 2026

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

• by Kathryn Wighton

• June 16, 2026

• 5 min

Machine-learning prediction of impaired outcome in diabetic patients undergoing non-cardiac surgery

• by Xiaojun Liu, Xueqing Chen, Lin Liu, Yuanyuan Lv

• June 5, 2026

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.

• by Julia Cipriano, MS, CMPP

• June 26, 2026

• 4 min